P150016S004

None

FDA Premarket Approval P150016 S004

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP150016S004
Classification NameNone
Applicant
PMAP150016
SupplementS004

Supplemental Filings

Supplement NumberDateSupplement Type
P150016Original Filing
S022 2022-08-08 30-day Notice
S021 2021-08-16 30-day Notice
S020 2021-01-14 30-day Notice
S019
S018 2020-05-01 135 Review Track For 30-day Notice
S017 2019-01-23 30-day Notice
S016 2018-08-17 30-day Notice
S015 2018-06-27 30-day Notice
S014 2018-05-14 30-day Notice
S013 2018-04-06 30-day Notice
S012 2018-01-22 Real-time Process
S011 2018-01-09 30-day Notice
S010 2017-11-29 Normal 180 Day Track No User Fee
S009 2017-11-28 135 Review Track For 30-day Notice
S008 2017-11-28 30-day Notice
S007 2017-11-28 30-day Notice
S006 2017-10-23 30-day Notice
S005 2017-04-10 Real-time Process
S004
S003 2016-10-25 30-day Notice
S002 2016-10-19 30-day Notice
S001 2016-06-29 30-day Notice

NIH GUDID Devices

Device IDPMASupp
10801741099387 P150016 000
10801741099363 P150016 000
20801741099377 P150016 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.